Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03762018
Title BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma (BEAT-meso)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors European Thoracic Oncology Platform
Age Groups: senior | adult
Covered Countries ITA | GBR | FRA | ESP | BEL

No variant requirements are available.